# A Single-arm, Phase II, Multi-center Clinical Trial of Sintilimab During the Perioperative Period in Patients With Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma

> **NCT07379424** · PHASE2 · NOT_YET_RECRUITING · sponsor: **chen chao Professor** · enrollment: 37 (estimated)

## Conditions studied

- Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma

## Interventions

- **COMBINATION_PRODUCT:** Adjuvant therapy: sintilimab combined with radiotherapy

## Key facts

- **NCT ID:** NCT07379424
- **Lead sponsor:** chen chao Professor
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01-28
- **Primary completion:** 2027-08-25
- **Final completion:** 2028-08-25
- **Target enrollment:** 37 (ESTIMATED)
- **Last updated:** 2026-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07379424

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07379424, "A Single-arm, Phase II, Multi-center Clinical Trial of Sintilimab During the Perioperative Period in Patients With Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT07379424. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*